Table 4 Comparing our results with other studies
Study | n | Duration of TKI, m | Clinical stage, n (%) | Surgery, n (%) | Post operative complications, n | Adjuvant TKI, Y/N/U | PFS/OS, m |
|---|---|---|---|---|---|---|---|
Ohtaki et al. [23] | 36 | 14 | IIIA, 8 (22.2) IIIB, 4 (11.1) IV, 21 (58.3) R, 3 (8.3) | Lobectomy, 28 (77.8) Segmentectomy, 3 (8.3) Wedge resection, 2 (5.6) Bilobectomy, 1 (2.8) Pneumonectomy, 2 (5.6) | Bleeding, 1 Empyema, 1 | 16/20/0 | 15/58 |
Song et al. [24] | 9 | 6 (2–46) | IIIA, 2 (22.2) IIIB, 1 (11.1) IV, 6 (66.7) | Lobectomy, 9 (100%) | Atrial fibrillation, 1 | 9/0/0 | 14/17 |
Yamamoto et al. [25] | 24 | 3 (0.7–36) | IB, 1 (4.2) IIIA, 8 (33.3) IIIB, 5 (20.8) IV, 10 (41.7) | Lobectomy, 15 (62.5) Bilobectomy, 5 (20.8) Pneumonectomy, 4 (16.7) | Empyema, 1 Chylothorax, 1 | 12/9/3 | 10/68 |
Ning et al. [26] | 10 | 3 (3–5) | IIIA, 2 (20) IIIB, 8 (80) | Lobectomy, 9 (90) Pneumonectomy, 1 (10) | Death, 1 | 9/0/0 | 14/36 |